Bayforest Capital LTD Blueprint Medicines Corp Transaction History

Bayforest Capital LTD

  • $210 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 28, 2025
BUY
$79.22 - $128.4 $87,062 - $141,111
1,099 Added 8453.85%
1,112 $143 Million
Q1 2025

May 08, 2025
SELL
$86.69 - $115.63 $248,973 - $332,089
-2,872 Reduced 99.55%
13 $0
Q4 2024

Feb 14, 2025
BUY
$82.48 - $101.39 $237,954 - $292,510
2,885 New
2,885 $252 Million

Others Institutions Holding BPMC

# of Institutions
368
Shares Held
66.9M
Call Options Held
973K
Put Options Held
1.54M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $7.73B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Bayforest Capital LTD Portfolio

Follow Bayforest Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayforest Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Bayforest Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email